# A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy

> **NCT01079351** · PHASE1 · COMPLETED · sponsor: **Lundbeck LLC** · enrollment: 98 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Intravenous Carbamazepine

## Key facts

- **NCT ID:** NCT01079351
- **Lead sponsor:** Lundbeck LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-03
- **Final completion:** 2009-04
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2010-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01079351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01079351, "A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01079351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*